货号:GS40812
Zampilimab (UCB-7858) is an investigational human monoclonal antibody of the IgG4-kappa isotype that targets tissue transglutaminase 2 (TG2 or TGM2). It is being developed for the treatment of celiac disease and other TG2-mediated disorders, aiming to inhibit the enzymatic activity and pathogenic functions of TG2, which plays a central role in the immune response to gluten.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯